Showing results (171-180 of 463) with videos related to
Sort By:
Pageof 47
Journal of Neurochemistry|July 2, 2004
Interference with ubiquitination causes oxidative damage and increased protein nitration: implications for neurodegenerative diseasesDong-Hoon Hyun, Douglas A Gray, Barry Halliwell, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Functional organization of the basal ganglia: therapeutic implications for Parkinson's diseaseJose A Obeso, Maria Cruz Rodríguez-Oroz, Beatriz Benitez-Temino, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 17, 2017
Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changesIgnacio Obeso, Enrique Casabona, Rafael Rodríguez-Rojas, et al.Clinical Neuropharmacology|June 11, 2004
Variation in the dopaminergic response during the day in Parkinson diseaseAlessandra Monge, Fabio Viselli, Fabrizio Stocchi, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 11, 2025
Deep transcranial magnetic stimulation in progressive supranuclear palsy: a randomized double-blind, cross-over studyFabiana Giada Radicati, Laura Vacca, Miriam Casali, et al.Parkinsonism & Related Disorders|March 5, 2013
Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-upSara Ortega-Cubero, Pedro Clavero, Cecilia Irurzun, et al.Parkinson'S Disease|October 24, 2015
The Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation TreatmentAna Kleiner, Manuela Galli, Maria Gaglione, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 7, 2003
HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's diseaseMarco Onofrj, Anna Lisa Luciano, Diego Iacono, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2011
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patientsFabrizio Stocchi, Rupam Borgohain, Marco Onofrj, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Long-term effects of rasagiline and the natural history of treated Parkinson's diseaseOlivier Rascol, Robert A Hauser, Fabrizio Stocchi, et al.Pageof 47